Contact Us
Drug Search Results
More Filters [+]

RD13-01

Alternative Names: rd13-01, rd13 01, rd1301
Latest Update: 2023-03-05
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CAR-T

Novel Mechanism: No

Modality: Cell Therapy

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: He Huang
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for RD13-01

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Oncology Hematological Unspecified|Oncology Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BHCT-RD13-01-03

N/A

Unknown status

Precursor Cell Lymphoblastic Leukemia-Lymphoma|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Acute Lymphoid Leukemia|T-Cell Leukemia

2021-11-15

BHCT-RD13-01-02

P1

Completed

Oncology Hematological Unspecified|Oncology Unspecified

2021-02-17

Recent News Events

Date

Type

Title

03/05/2023

PubMed

 CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting.

11/01/2022

PubMed

 Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions